Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response.
Lipid bodies (also known as lipid droplets) are emerging as inflammatory organelles with roles in the innate immune response to infections and inflammatory processes. In this study, we identified MCP-1 as a key endogenous mediator of lipid body biogenesis in infection-driven inflammatory disorders and we described the cellular mechanisms and signaling pathways involved in the ability of MCP-1 to regulate the biogenesis and leukotriene B4 (LTB4) synthetic function of lipid bodies. In vivo assays in MCP-1-/- mice revealed that endogenous MCP-1 produced during polymicrobial infection or LPS-driven inflammatory responses has a critical role on the activation of lipid body-assembling machinery, as well as on empowering enzymatically these newly formed lipid bodies with LTB4 synthetic function within macrophages. MCP-1 triggered directly the rapid biogenesis of distinctive LTB4-synthesizing lipid bodies via CCR2-driven ERK- and PI3K-dependent intracellular signaling in in vitro-stimulated macrophages. Disturbance of microtubule organization by microtubule-active drugs demonstrated that MCP-1-induced lipid body biogenesis also signals through a pathway dependent on microtubular dynamics. Besides biogenic process, microtubules control LTB4-synthesizing function of MCP-1-elicited lipid bodies, in part by regulating the compartmentalization of key proteins, as adipose differentiation-related protein and 5-lipoxygenase. Therefore, infection-elicited MCP-1, besides its known CCR2-driven chemotactic function, appears as a key activator of lipid body biogenic and functional machineries, signaling through a microtubule-dependent manner.
Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Patricia
P
Pacheco
Adriana
A
Vieira-de-Abreu
Rachel N
RN
Gomes
Giselle
G
Barbosa-Lima
Leticia B
LB
Wermelinger
Clarissa M
CM
Maya-Monteiro
Adriana R
AR
Silva
Marcelo T
MT
Bozza
Hugo C
HC
Castro-Faria-Neto
Christianne
C
Bandeira-Melo
Patricia T
PT
Bozza
D000818:Animals; D018932:Chemokine CCL2 / Q000235:genetics / Q000502:physiology*; D002633:Chemotaxis; D019446:Endotoxemia / Q000276:immunology / Q000382:microbiology; D007113:Immunity, Innate; D007975:Leukotriene B4 / Q000378:metabolism*; D008024:Ligands; D050356:Lipid Metabolism / Q000235:genetics; D008070:Lipopolysaccharides / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D008870:Microtubules / Q000378:metabolism*; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D054390:Receptors, CCR2 / Q000378:metabolism; D018805:Sepsis / Q000276:immunology* / Q000382:microbiology
C515335:Ccr2 protein, mouse; D018932:Chemokine CCL2; D008024:Ligands; D008070:Lipopolysaccharides; D054390:Receptors, CCR2; D007975:Leukotriene B4; D019869:Phosphatidylinositol 3-Kinases; D019950:Mitogen-Activated Protein Kinase 1